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The prevalence of atherosclerotic vascular disease,
manifesting as cardiovascular, cerebrovascular or pe-
ripheral arterial disease, is known to be markedly in-
creased in diabetic subjects compared to non-diabetic
subjects [1–4]. Symptoms of cerebral ischaemia and
infarction have been associated with the presence of
severe atherosclerotic carotid artery disease [4–9].
Carotid atherosclerosis has been investigated by
means of autopsy, angiography, clinical symptoms
and non-invasive ultrasound techniques. Epidemio-
logical studies focused either on the prevalence of ca-
rotid artery stenosis (CAS) in symptomatic subjects
[4–6, 8, 9], or in asymptomatic subjects [10–17],
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Summary Cross-sectional associations between ca-
rotid artery stenosis (CAS) on the one hand, and pa-
rameters of glycaemia and specific insulin levels on
the other, were investigated in an age, sex, and glu-
cose tolerance stratified random sample from a 50–
74-year-old Caucasian population. Subjects treated
with insulin or oral hypoglycaemic agents were classi-
fied as having known diabetes mellitus (KDM)
(n = 66). Using two oral glucose tolerance tests, and
based on the World Health Organisation criteria, all
other participants were classified as having a normal
(NGT) (n = 287), an impaired (IGT) (n = 169) or a
diabetic (NDM) (n = 106) glucose tolerance. CAS
was defined haemodynamically using duplex scan-
ning. The crude prevalences of only moderate (16–
49%) CAS were 6.6%, 7.1%, 5.7% and 12.1% in
NGT, IGT, NDM and KDM subjects, respectively.
For any severe ( ‡ 50%) CAS, crude prevalences
were 2.8 %, 4.7%, 9.4% and 7.6%. The prevalence
of any severe CAS was higher in NDM (p < 0.01)
and KDM subjects (p = 0.07) than in NGT subjects.
The prevalence of a history of stroke or transient
ischaemic attack was 1.7%, 1.8%, 2.8% and 1.5%
in NGT, IGT, NDM and KDM, respectively. In uni-
variate logistic regression analysis, HbA1c, serum
fructosamine, fasting and 2-h post-load glucose were
significantly associated with any severe CAS. In mul-
tivariate analyses controlling for other risk factors,
only HbA1 c and 2-h post-load plasma glucose re-
mained significantly associated (odds ratios: 1.29 per
% and 1.09 per mmol/l, respectively) in separate
models. No association could be shown between ei-
ther fasting or 2-h post-load specific insulin and any
severe CAS in either univariate or multivariate
analyses. In conclusion, HbA1 c and 2-h post-load
plasma glucose are independently associated with
any severe CAS, whereas specific insulin is not. [Dia-
betologia (1997) 40: 290–298]
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irrespective of blood glucose level. In only a few stud-
ies, was the prevalence of CAS determined in subjects
with non-insulin-dependent diabetes mellitus
(NIDDM) [18, 19]. To date, very few studies have in-
cluded the total range of blood glucose level and re-
ported its association with CAS in a population-based
sample.
To study asymptomatic carotid artery disease,
combined echo-Doppler (duplex) examination has
been used in many epidemiological and clinical stud-
ies [4–19]. In the Hoorn Study, the evaluation of the
duplex flow velocity curves was chosen as the non-in-
vasive test to diagnose CAS, as it is easily and quickly
performed without discomfort for the participant and
can accurately be scored on-line. The Hoorn Study
took place from 1989 to 1992. It was a population-
based cross-sectional survey to determine the preva-
lence of abnormal glucose tolerance, its determi-
nants, and its related disorders in an elderly Dutch
Caucasian population [20–23]. In contrast to methods
used in all other population-based studies, glucose
tolerance was evaluated with two oral glucose toler-
ance tests (OGTT) to optimize the diagnostic preci-
sion, and insulin levels were measured with a specific
insulin assay.
The aims of this study were to determine: 1) the
prevalence of CAS in an elderly Caucasian popula-
tion; 2) the association of CAS with various parame-
ters of blood glucose level and specific insulin levels;
and 3) the eventual confounding of these associations
by other cardiovascular risk factors.
Subjects and methods
Subjects. All study participants were involved in the Hoorn
Study, a cross-sectional survey on disturbances of glucose toler-
ance and diabetes-related disorders in a general Caucasian
population. For this study, a random sample of 50–74-year-old
subjects was taken from the population register of the town of
Hoorn (59000 inhabitants) in the Netherlands. Of the 3553
subjects invited for the study, 2540 (71.5%) participated, of
whom 56 were excluded from analysis and further study be-
cause they were non-Caucasian. Thus, the final Hoorn Study
cohort consisted of 2484 subjects. Information on age, sex,
body height, weight, history of diabetes, treatment for hyper-
tension and cardiovascular complaints was obtained by inter-
view from virtually all non-participants (93%). The non-par-
ticipants were only slightly, but significantly older (63.1 vs
61.7 years), taller (171 vs 169 cm), lighter (73.1 vs 75.5 kg),
and less often had a family history of diabetes (20 vs 27 %).
They did not differ significantly from our study population
with respect to sex, self-reported diabetes, treatment for hyper-
tension and cardiovascular symptoms.
The sampling procedure has already been described in de-
tail [20]. Briefly, all cohort members not treated with oral hy-
poglycaemic agents or insulin underwent a 75-g OGTT, ac-
cording to World Health Organisation (WHO) recommenda-
tions [24] (phase 1). All cohort members with a 2-h post-load
plasma glucose level 11.1 mmol/l or more (n = 122), and age
and sex-stratified random samples from subjects with a 2-h
post-load glucose level 7.5 mmol/l or more and less than
11.1 mmol/l (n = 254; mean sample fraction 81 %), as well as
from those with a 2-h post-load glucose level less than
7.5 mmol/l (n = 256; mean sample fraction 13 %) were invited
for a second OGTT (phase 2) and a study of diabetes-related
disorders (phase 3). Sample fractions were chosen in such a
way that approximately equal numbers of participants in each
age, sex, and glucose tolerance stratum would be obtained. Co-
hort members treated with oral hypoglycaemic agents or insu-
lin (n = 76) only had their fasting plasma glucose measured
once, and were all asked to participate in the diabetes-related
disorder study (phase 3). Thus, a total of 708 subjects were in-
vited for the assessment of CAS.
The Hoorn Study was approved by the ethical review com-
mittee of the Academic Hospital of the Vrije Universiteit and
informed consent was obtained from all participants.
Non-invasive assessment of CAS. Ultrasonography of the ca-
rotid arteries was performed using a colour Duplex scanner
(Acuson 128, Mountain View, Calif., USA). Haemodynamic
stenosis of the carotid arteries was assessed by using a 7.5-
MHz linear transducer in combination with a 5-MHz pulsed
doppler. The results were registered by two experienced vascu-
lar technicians under the supervision of a vascular surgeon
(A.M.). The final interpretation of the doppler flow velocity
profiles was made according to standard criteria [25–27] by
one vascular surgeon (A.M.) blinded for the glucose tolerance
status and the history of stroke or transient ischaemic attack
(TIA). Recordings were taken from the proximal and distal
common, the external, and also the proximal and distal inter-
nal carotid artery on both sides. Recording started after a 15-
min resting period in a supine position (room temperature
23 ° C).
Each carotid branch was classified as having no or minimal
stenosis (0–15 % diameter reduction defined as a systolic peak
flow velocity < 1.25 m/s and no spectral broadening), moderate
stenosis (16–49 % diameter reduction defined as a systolic
peak flow velocity < 1.25 m/s and spectral broadening through-
out systole) or severe stenosis ( ‡ 50 % diameter reduction de-
fined as a systolic peak flow velocity > 1.25 m/s, or occlusion
corresponding with the absence of carotid arterial flow) [25–
27]. Finally, using the data from the most affected carotid
branch, the participants were classified as having no or mini-
mal CAS or any CAS (any CAS > 15 %). This last category
consisted of subjects having only moderate CAS (16–49 %
stenosis) or any severe CAS (50–100 % stenosis).
A reproducibility study of this non-invasive test was per-
formed on a random sample (n = 41), the second measurement
being performed 4 to 11 months after the first registration. The
agreement between the first and the repeated classification
was expressed as kappa value. The weighted kappa value was
0.41, indicating a fair to moderate agreement [28].
Parameters of glycaemic and insulin levels. Fasting and 2-h
post-load venous plasma glucose levels were determined with
a glucose dehydrogenase method (Merck, Darmstadt, Ger-
many) in the laboratory of the Academic Hospital of the Vrije
Universiteit in Amsterdam. In diabetic subjects treated with
oral hypoglycaemic agents or insulin, fasting plasma glucose
and fasting serum insulin (in duplicate) were measured on
one occasion only.
Fasting and 2-h post-load specific serum insulin levels were
quantified (in duplicate) with an insulin-specific double-anti-
body radioimmunoassay (antibody: Linco SP21, St. Louis,
Mo., USA). No cross-reactivity with proinsulin or split proin-
sulin was found. The intra-assay and inter-assay coefficients of
variation for insulin were 5–8 % and 7–11 %, respectively.
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Glycated haemoglobin (HbA1 c) was determined once by
ion-exchange high-performance liquid chromatography, using
a Modular Diabetes Monitoring System (Bio-Rad, Vee-
nendaal, the Netherlands: normal range 4.3–6.1 %). Serum
fructosamine concentrations were measured once, using a sec-
ond generation serum fructosamine assay (Roche Diagnostica,
Basle, Switzerland). The inter-assay coefficient of variation in
the normal range was 4.6 %; in the pathological range 3.0 %.
Subjects treated with oral hypoglycaemic agents or insulin
were classified as having known diabetes mellitus (KDM). All
non-KDM subjects, including previously diagnosed diabetic
patients with dietary advice only, were classified according to
the WHO criteria [24] applied to mean fasting and mean 2-h
post-load plasma glucose values of two OGTTs. In 25 subjects,
at least one glucose value was missing at the second OGTT.
These missing values were substituted by values from the first
OGTT. Thus, in addition to the KDM category, the following
three glucose tolerance categories were discerned: normal glu-
cose tolerance (NGT), impaired glucose tolerance (IGT), and
newly diagnosed diabetes mellitus (NDM).
Potential confounding factors. Concentrations of serum lipids
were determined in the fasting blood samples of all subjects at
the first OGTT. Total cholesterol, HDL-cholesterol (after pre-
cipitation of the low and very low-density lipoproteins [29])
and triglycerides were measured by enzymatic techniques
(Boehringer-Mannheim, Mannheim, Germany). The Friede-
wald formula was used to calculate the LDL-cholesterol [30].
This formula was not applied to subjects with serum triglycer-
ide levels over 8.0 mmol/l (n = 3). As the inclusion of subjects
with triglyceride levels between 4.5 and 8.0 mmol/l (n = 20)
barely influenced the studied associations, they were not ex-
cluded from further analyses.
Systolic and diastolic (Korotkov V) blood pressure was de-
termined before the start of both OGTTs on the right arm of
seated subjects, after at least 5 min resting, using a random-
zero sphygmomanometer (Hawksley-Gelman Ltd., Lancing,
Sussex, UK). The average of duplicate measurements on these
two occasions was used for analysis. Hypertension was defined
as present treatment with antihypertensive drugs or having an
elevated blood pressure (diastolic > 95 mmHg or sys-
tolic > 160 mmHg).
Height, weight and body circumferences were measured on
all subjects, barefoot and wearing light clothes only, at the end
of the first visit. Body mass index (BMI) was calculated as
weight (kg) divided by height squared (m2). Waist/hip-ratio
(WHR) was defined as waist circumference divided by hip cir-
cumference.
The medical history was obtained by means of a self-admin-
istered questionnaire. The subjects were asked whether they
had received any specialist medical care during the past
10 years and, if so, for what reason and from which specialism.
The history of macrovascular disease (myocardial infarction,
angina pectoris, intermittent claudication, stroke, brain haem-
orrhage or transient palsy) was assessed by using a Dutch
translation of the questionnaire from the London School of
Hygiene and Tropical Medicine [31], which was also used in
the Zutphen Study [32]. The general practitioners of those sub-
jects reporting any macrovascular disease were asked to verify
the indicated symptoms. Stroke or TIA was defined as a self-
reported history of stroke or brain haemorrhage, or as perma-
nent or transient palsy confirmed either by the general practi-
tioner or by the use of platelet aggregation inhibitors without
a history of cardiovascular disease. Information on family his-
tory of vascular disease was obtained by asking the participants
whether any of their grandparents, parents, brothers or sisters
had experienced any of the above-mentioned diseases before
the age of 60 years. Smoking was expressed on a dichotomized
scale (ever vs never smoked cigarettes, cigars or pipe) and on a
continuous scale (cigarette pack-years). On their first visit to
the study centre, the participants brought with them any medi-
cation they were currently using and the completed question-
naire. The answers on the questionnaire were checked for
completeness and consistency, and the names of the medica-
tion and the dosages prescribed were registered.
Statistical analysis
The differences in characteristics between subjects in various
glucose tolerance categories were assessed by using the one-
way analysis of variance for the continuous parameters, and
the chi-squared test for proportions. If the expected frequen-
cies were less than 5, the Fisher’s exact test was used. Because
the distribution of the serum insulin levels was skewed, the
Mann-Whitney test was used to evaluate differences in insulin
levels between various glucose tolerance categories. In further
analyses, insulin data were logarithmically transformed. The
chi-square test for trend was used to investigate linear trends
of the prevalence of CAS over the NGT, IGT and NDM cate-
gories.
To assess the population-based prevalence, the frequency
of CAS was determined in 12 strata of the phase 3 cohort
(age: 50–59, 60–69 and 70–74-years old; glucose tolerance cate-
gory of the first OGTT: NGT, IGT, NDM and KDM). The
prevalence of CAS in the original population-based sample
(n = 2484) was estimated from the contributions of each age
and glucose tolerance category stratum, based on the results
of the first OGTT. Weighted stratum-specific variances were
used to compute 95 % confidence intervals (95% CI).
At first, a univariate logistic regression analysis was per-
formed with the glucose tolerance category as independent,
and any severe CAS as the dependent variable. Seven multi-
variate logistic regression analyses, each correcting for the in-
fluence of age, sex, BMI, WHR, smoking behaviour, hyperten-
sion, triglycerides, LDL and HDL-cholesterol, and family his-
tory of cardio or cerebrovascular disease, were performed to
assess the contribution of each of the five glycaemic indices
(glucose tolerance category, fasting and 2-h post-load plasma
glucose, HbA1c, and serum fructosamine), and the fasting and
2-h post-load specific insulin levels to the prevalence of CAS.
Because no OGTT was performed on diabetic subjects treated
with oral hypoglycaemic drugs or insulin, these subjects were
not included in the analyses using the 2-h post-load plasma glu-
cose and insulin levels. In all analyses, a p-value of less than
0.05 was regarded as statistically significant.
Results
Study population. As reported previously, the re-
sponse-rate for phase 3 was 89 % (631 of 708) [20].
Reasons for non-response were refusal to participate
(n = 57), inability to visit the study centre before the
end of the study (n = 15), moving out of Hoorn
(n = 2), language problems (n = 2) and hospitaliza-
tion (n = 1).
In the non-participant group of phase 3, the per-
centage of female subjects was significantly higher,
whereas age, hypertension, self-reported cerebrovas-
cular symptoms (stroke, brain haemorrhage, or either
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permanent or transient palsy), myocardial infarction,
angina pectoris and intermittent claudication did not
differ significantly between participants and non-par-
ticipants. The absence of differences in prevalence
rates of hypertension and cardiovascular disease sug-
gests that the non-response was not associated with
the presence of macrovascular disease. For technical
reasons, the non-invasive assessment of three partici-
pants was not possible.
Characteristics of participants. Based on the mean
fasting and 2-h post-load plasma glucose levels of
two OGTTs and the WHO criteria, the study cohort
was divided into three glucose tolerance categories:
NGT (n = 287), IGT (n = 169) and NDM (n = 106),
apart from KDM (n = 66, of whom 52 were treated
with oral hypoglycaemic agents and 14 with insulin).
Glycaemic indices, insulin levels, and other puta-
tive determinants of CAS are listed in Table 1.
Some of these characteristics have been reported be-
fore [20]. As expected, glycaemic indices increased
stepwise from NGT via IGT and NDM to KDM.
The fasting serum insulin level in the KDM group
was non-significantly lower than in the NDM group
(p = 0.52), whereas the 2-h post-load insulin level in
NDM subjects was lower than in IGT subjects
(p = 0.02). Because the distribution of the serum in-
sulin levels and amount of smoking were skewed,
values are represented as median (20th, 80th percen-
tile).
The percentage of never smoked was highest in
KDM subjects, but they had the highest mean ciga-
rette consumption (pack-years). WHR, BMI, HDL-
cholesterol, triglycerides and systolic blood pressure
were less favourable in the IGT, NDM and KDM cat-
egories than in the NGT. The percentage of hyperten-
sive subjects increased over the respective glucose
tolerance categories.
Prevalence of CAS in relation to glucose tolerance cat-
egory. The crude prevalences of any CAS ( > 15%
stenosis in any carotid branch), only moderate CAS
(16–49% stenosis) and any severe CAS ( ‡ 50%
stenosis in any carotid branch) are shown in Table 2.
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Table 1. Characteristics of the study population stratified for glucose tolerance in phase 3 of the Hoorn Study
Glucose tolerance Normal glucose
tolerance
(n = 287)
Impaired glucose
tolerance
(n = 169)
Newly diagnosed
diabetes
(n = 106)
Known diabetes
(n = 66)
Demographic data
Age (years) 63.0 – 7.4 64.9 – 7.0b 65.9 – 6.5b 65.4 – 7.2
Sex (% male) 52 47 46 39
Parameters of glucose metabolism
Fasting glucose (mmol/l) 5.4 – 0.5 6.1 – 0.7b 8.4 – 3.1b 11.0 – 3.7b
2-h post-load glucose (mmol/l) 5.6 – 1.4 9.1 – 0.9b 15.6 – 5.5b –
HbA1c (% of total haemoglobin) 5.3 – 0.5 5.6 – 0.5
b 6.7 – 1.8b 8.0 – 1.6b
Serum fructosamine (mmol/l) 240 – 17 246 – 19 286 – 69b 335 – 66b
Fasting insulin (pmol/l) 73
(52, 99)
90b
(61, 147)
112b
(74, 163)
103b
(73, 148)
2-h post-load insulin (pmol/l) 303
(159, 462)
607b
(351, 1193)
508b
(242, 956)
–
Confounding risk factors
Smoking status:
never smoked (%) 31 35 37 39
ex-smoker (%) 36 39 39 36
current smoker (%) 33 26 25 24
Smokinga (pack-years) 26.2
(9.6, 41.6)
22.0
(9.8, 42.4)
24.0
(10.8, 45.9)
27.4
(17.0, 44.4)
Waist/hip-ratio 0.90 – 0.08 0.93 – 0.08b 0.96 – 0.09b 0.94 – 0.08b
Body mass index (kg/m2) 26.0 – 3.3 27.7 – 3.7b 28.6 – 4.1b 29.1 – 5.2b
LDL-cholesterol (mmol/l) 4.61 – 1.03 4.63 – 1.02 4.26 – 1.16b 4.26 – 1.01
HDL-cholesterol (mmol/l) 1.38 – 0.39 1.23 – 0.34b 1.13 – 0.27b 1.17 – 0.27b
Triglycerides (mmol/l) 1.49 – 0.74 1.97 – 1.10b 2.50 – 1.98b 2.31 – 1.45b
Hypertension (%) 24.4 45.6b 52.8b 59.1b
antihypertensive drugs (%) 17.1 33.1b 35.8b 51.5b
Blood pressure (mmHg)
diastolic 81 – 10 85 – 10b 84 – 9b 81 – 12
systolic 133 – 18 144 – 20b 145 – 17b 143 – 21b
Family history of:
myocardial infarction (%) 14.3 13.0 17.9 21.2
stroke (%) 8.0 8.9 2.8 15.2
Values are mean – SD, percentage or median (20th, 80th percentile).
a Never smokers are excluded.
b P-value < 0.05 vs normal glucose tolerance
The prevalence of any CAS increased gradually
from 9.4 % in NGT subjects to 19.7% in KDM sub-
jects. The prevalence of only moderate CAS was sim-
ilar in NGT, IGTand NDM subjects (6.6%, 7.1% and
5.7%, respectively) and was 12.1% in the KDM cate-
gory. The crude prevalence of any severe CAS in-
creased stepwise from 2.8% in NGT, via 4.7% in
IGT to 9.4% and 7.6% in NDM and KDM, respec-
tively. The chi-square test for trend over the NGT,
IGT and NDM categories was highly significant for
any severe CAS (p < 0.01). The same holds for any se-
vere external CAS (p < 0.005). The prevalence of any
severe CAS was significantly higher in NDM than in
NGT (p < 0.01), whereas the difference between
KDM and NGT was borderline significant (p = 0.07).
No significant differences were found between IGT
and NGT (p = 0.41), IGT and NDM (p = 0.20), IGT
and KDM (p = 0.59), and, NDM and KDM
(p = 0.89).
The prevalence of stroke or TIA (confirmed
self-reported cerebrovascular disease) was 1.7%,
1.8%, 2.8% and 1.5%, in the respective glucose
tolerance categories (chi-square test for trend;
p = 0.79).
Prevalence of CAS in a general Dutch Caucasian
population. Table 3 shows the calculated age-specific
prevalence rates of any CAS and any severe CAS in
a general Dutch Caucasian population in the town
of Hoorn. Because some contributing strata are
small, 95% confidence intervals (95% CI) are wide.
The calculated population-based prevalences (95%
CI) in 50–74-year-old subjects of any CAS and any
severe CAS are 9.0% (6.3–11.7%) and 3.0% (1.5–
4.5%), respectively. The prevalences of both any
CAS and any severe CAS were significantly higher
in the 70–74-year-old subjects than in the 50–59 or
60–69-year-old subjects. No significant differences
were found between 50–59 and 60–69-year-old sub-
jects.
Determinants of any severe CAS. At first, logistic re-
gression analyses were performed using four dichoto-
mous dependent variables: a) only moderate CAS vs
no or minimal CAS, b) any severe CAS vs no or min-
imal CAS, c) any severe CAS vs a combination of no
or minimal CAS and only moderate CAS and, d)
any CAS vs no or minimal CAS.
Cardiovascular risk factors were weakly and non-
significantly associated with only moderate CAS
(16–49% stenosis) contrasted with no or minimal
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Table 2. Prevalence of carotid artery stenosis according to glucose tolerance category
Category of
carotid artery-
stenosis
Normal glucose
tolerance (n = 287)
Impaired glucose
tolerance (n = 169)
Newly diagnosed
diabetes (n = 106)
Known diabetes
(n = 66)
% (n) % (n) % (n) % (n) p-valuea
Common carotid artery
Any 0.7 (2) 1.8 (3) 1.9 (2) 7.6 (5) 0.27
Moderate 0.3 (1) 0.6 (1) 1.9 (2) 7.6 (5) 0.14
Severe 0.3 (1) 1.2 (2) 0.0 (0) 0.0 (0) 0.98
Internal carotid artery
Any 7.7 (22) 9.5 (16) 13.2 (14) 16.9 (11) 0.10
Moderate 5.6 (16) 6.5 (11) 7.5 (8) 10.8 (7) 0.41
Severe 2.1 (6) 3.0 (5) 5.7 (6) 6.2 (4) 0.08
External carotid artery
Any 2.1 (6) 6.5 (11) 9.4 (10) 9.1 (6) 0.001
Moderate 1.7 (5) 4.7 (8) 4.7 (5) 4.5 (3) 0.06
Severe 0.3 (1) 1.8 (3) 4.7 (5) 4.5 (3) < 0.005
Any carotid artery
Any 9.4 (27) 11.8 (20) 15.1 (16) 19.7 (13) 0.11
Only moderate 6.6 (19) 7.1 (12) 5.7 (6) 12.1 (8) 0.93
Any severe 2.8 (8) 4.7 (8) 9.4 (10) 7.6 (5) < 0.01
%, Percentage of subjects with CAS per glucose tolerance ca-
tegory;
(n), number of subjects with CAS per stratum;
any CAS, stenosis > 15 %: sum of prevalences of moderate
CAS (stenosis 16–49 %) plus severe CAS (stenosisL 50 %);
moderate CAS, stenosis 16–49 %;
severe CAS, stenosisL 50 %;
a P-values of chi-square tests for trend over normal glucose tol-
erance, impaired glucose tolerance and newly detected dia-
betes
Table 3. Calculated population-based age-specific prevalences
of carotid artery stenosis in Hoorn, the Netherlands, 1989–
1992
Age-
category
(years)
Any carotid artery
stenosis (> 15%)
Any severe carotid artery
stenosis (L 50%)
% 95% Cl % 95% Cl
50–59 6.1 % 2.1–10.1% 1.8 % 0.0–4.1%
60–69 8.3 % 4.2–12.5% 2.6 % 0.8–4.4%
70–74 18.8% 11.7–25.9% 7.3 % 2.6–12.0%
All ages
50–74 9.0 % 6.3–11.7% 3.0 % 1.5–4.5%
CAS (0–15% stenosis) as reference category.
However, the same risk factors were significantly
associated with any severe CAS ( ‡ 50% stenosis)
compared to no or minimal CAS (0–15% stenosis).
Similar associations were found contrasting any se-
vere CAS (‡ 50% stenosis) with a combination of
no or minimal CAS and only moderate CAS
( < 50% stenosis) as reference category. If any CAS
(only moderate CAS or any severe CAS; > 15%
stenosis) was contrasted with no or minimal CAS
(0–15% stenosis), the odds ratios of the various car-
diovascular risk factors decreased, but remained sig-
nificant. Therefore, we decided to perform logistic
regression analyses with the indicator variable any
severe CAS (present vs absent) as the dependent
variable.
Firstly, the odds ratios for IGT, NDM or KDM vs
NGT were calculated to estimate the relative risk for
any severe CAS in the respective glucose tolerance
categories. In the univariate logistic regression analy-
sis, NDM subjects had a significantly higher risk for
any severe CAS than NGT subjects (odds ratio
(OR): 3.63; p = 0.0001), whereas this was not found
for either IGT (OR: 1.73; p = 0.28) or KDM (OR:
2.86; p = 0.07) subjects. Combining the NDM and
KDM subjects into one diabetes category, the OR
was 3.33 (p = 0.01). In the multivariate analyses, the
ORs of NDM and diabetic subjects for any severe
CAS decreased and were no longer statistically signif-
icant (2.73; p = 0.08 and 2.48; p = 0.09, respectively).
No increased risk could be demonstrated for IGT or
KDM subjects compared to NGT subjects in the mul-
tivariate analysis.
In the multivariate analyses any severe CAS was
significantly associated with HbA1c (OR: 1.29 per%
increase; p = 0.03) and borderline significantly asso-
ciated with serum fructosamine (OR: 1.06 per
10 mmol/l; p = 0.07), whereas no significant associa-
tion with fasting plasma glucose was found (OR:
1.10 per mmol/l; p = 0.13). After exclusion of the sub-
jects treated with oral hypoglycaemic agents or insu-
lin, these associations were no longer significant
(data not shown). However, in the same sub-group,
the 2-h post-load plasma glucose level was signifi-
cantly associated with any severe CAS (OR: 1.09 per
mmol/l; p = 0.03).
No univariate or multivariate associations could
be shown between either fasting or 2-h post-load spe-
cific insulin and CAS. Even after exclusion of KDM
subjects, no associations were found.
The best fitting multivariate logistic regression
model, including HbA1 c as the parameter of glycae-
mic level, revealed that among the cardiovascular
risk indicators only age (OR: 1.10; 95% CI: 1.03–
1.17 per year older), HDL-cholesterol (OR: 0.78;
95% CI: 0.66–0.93 per 0.1 mmol/l increase), and
BMI (OR: 0.89; 95 % CI: 0.78–1.00 per kg/m2) con-
tributed significantly to the risk for any severe CAS.
Remarkably, smoking behaviour (OR: 1.30; 95% CI:
0.46–3.67 ever vs never smoked), hypertension (OR:
1.92; 95% CI: 0.86–4.29 present vs absent), triglycer-
ides (OR: 0.98; 95% CI: 0.65–1.48 per mmol/l), and
LDL-cholesterol (OR: 1.12; 95 % CI: 0.78–1.62 per
mmol/l) were not significantly associated with any se-
vere CAS.
In KDM subjects (n = 66), no significant associa-
tions were found between HbA1c (OR: 1.71; 95%
CI: 0.93–3.13 per %), fasting plasma glucose (OR:
1.04; 95% CI: 0.82–1.33 per mmol/l), serum fruc-
tosamine (OR: 2.85; 95% CI: 0.63–12.93 per
100 mmol/l) or fasting specific insulin (OR: 0.79;
95% CI: 0.19–3.39 per 100 pmol/l) and any severe
CAS in univariate logistic regression analyses. HDL-
cholesterol (OR: 0.62; 95% CI: 0.40–0.97 per
0.1 mmol/l) and diastolic blood pressure (OR: 0.90;
95% CI: 0.82–0.99 per mmHg) were significantly as-
sociated with any severe CAS in univariate analyses,
whereas all other cardiovascular risk indicators were
not. The small number of treated diabetic subjects
prevented multivariate analyses within the KDM
group.
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Table 4. Odds ratios for any severe carotid artery stenosisa of
various parameters of glucose tolerance
Parameter of glucose
metabolism
Odds
ratiob
95% Confi-
dence interval
p-value
Degree of glucose tolerancec
Impaired vs normal 1.30 0.45–3.79 0.63
New diabetes vs normal 2.73 0.89–8.33 0.08
Known diabetes vs normal 2.09 0.57–7.68 0.27
New + known diabetes vs
normal 2.48 0.88–7.01 0.09
Fasting plasma glucosec
per mmol/l 1.10 0.97–1.25 0.13
2-h plasma glucosed
per mmol/l 1.09 1.01–1.18 0.03
HbA1c
c
per % 1.29 1.02–1.63 0.03
Serum fructosaminec
per 10 mmol/l 1.06 1.00–1.13 0.07
Fasting specific insulinc
per 100 pmol/l 1.01 0.44–2.30 0.98
per ln unit 1.03 0.39–2.75 0.95
2-h specific insulind
per 100 pmol/l 0.98 0.89–1.08 0.63
per ln unit 0.84 0.47–1.50 0.55
a Haemodynamic stenosisL 50 % (systolic peak flow velocity
> 1.25 m/s or no arterial flow detectable);
b Multivariate logistic regression analyses; each model consist-
ed of the parameter of glucose metabolism at issue and the
following possibly confounding cardiovascular risk factors:
age, sex, smoking behaviour, W/H-ratio, BMI, LDL-cholester-
ol, HDL-cholesterol, triglycerides, hypertension and family
history of cardio- or cerebrovascular disease;
c Diabetic subjects treated with oral hypoglycaemic agents or
insulin included;
d Diabetic subjects treated with oral hypoglycaemic agents or
insulin excluded
Discussion
Prevalence data concerning non-invasively diagnosed
CAS in various glucose tolerance categories are
sparse. To our knowledge, this is the first population-
based survey to determine the prevalence of CAS in
NGT, IGT, NDM and KDM subjects in one cohort.
One previous study reported a prevalence of 7.9%
[18] of any severe CAS in NIDDM subjects treated
with sulphonylurea or insulin, which is similar to our
results (7.6%). In recently diagnosed NIDDM sub-
jects a prevalence of 4.4 % (95% CI: 1.2–11.3%) for
any severe CAS was reported [19]. This is about half
the prevalence in Hoorn (9.4%), which may partly
be explained by the younger age (35–75 years), possi-
bly a better glycaemic control (median fasting blood
glucose 7.7 mmol/l) and the small number of subjects
(n = 68) in the latter study. Our data show that the
prevalence of non-invasively diagnosed only moder-
ate CAS is similar in NGT, IGT and NDM subjects
and seems to be increased in KDM subjects only.
The prevalence of any severe CAS in any carotid
branch increased with an increasing glycaemic level.
This also holds for any severe CAS in both the inter-
nal and the external carotid artery. In NDM subjects,
the prevalence was significantly higher than in NGT
subjects, in both the internal and the external carotid
artery. No significant difference in the prevalence of
CAS was found between KDM and IGT on the one
hand, and NGT subjects on the other. These findings
were confirmed by univariate logistic regression
analysis. Multiple logistic regression analysis con-
firmed that NDM subjects had a 2–3 fold increased
risk for any severe CAS. The strength of the associa-
tion is similar to the previously reported 2–4 fold in-
creased risk for cerebrovascular morbidity and mor-
tality among NDM subjects [1–4]. Our data differ
from the results of a Japanese study in which signifi-
cantly higher intima media thicknesses were shown
in mildly hyperglycaemic and IGT subjects [33]. Ac-
cording to the WHO criteria we included mildly hy-
perglycaemic subjects in the NGT group, which may
have resulted in a loss of contrast between our IGT
and NGT subjects. The small number of subjects
with any severe CAS (n = 31) may also explain why
the association between IGTor KDM and any severe
CAS did not reach statistical significance.
The Hoorn Study data show a population-based
prevalence of any severe CAS of 3.0% in the 50–74-
year-old cohort. A clearly higher prevalence is seen
in the subjects over 70 years of age. Estimates of the
prevalence of severe CAS vary across studies from
only 1.4% in the Rotterdam Study to 8% in the Fra-
mingham study [10–17]. This variance may partly be
explained by the differences in the methods of assess-
ing stenosis (e.g. duplex, continuous wave or percent-
age diameter reduction in B-mode image), in defini-
tion of severe CAS ( > 40 %, ‡ 50% or > 75 %), in
age, and in non-response. Because of the small num-
bers, sex differences could not be tested.
In logistic regression analyses, HbA1 c, 2-h post-
load glucose and serum fructosamine (borderline)
turned out to be risk factors for any severe CAS,
even after correction for other cardiovascular risk
factors. These associations between continuous pa-
rameters of glycaemia and duplex Doppler diagnosed
CAS have not been described before. Using intima
media thickness as parameter of carotid atherosclero-
sis, this association was also reported by O’Leary
et al. [34] and Shahar et al. [35], but contradicted by
Markussis [36]. NIDDM has been reported to be in-
dependently associated with CAS in many studies [4,
10, 12, 35, 37–39].
In our data, age and HDL-cholesterol levels are
the most important determinants of any severe CAS,
which is in agreement with the findings in other ca-
rotid atherosclerosis studies [12, 39]. Triglyceride
and LDL-cholesterol levels were not associated with
CAS, which might, at least partly, be explained by
the cross-sectional study design. Selective mortality
may also be involved. Furthermore, LDL-cholesterol
is reported to become a less important cardiovascular
risk factor in elderly subjects [12, 40]. The lack of as-
sociation between triglycerides and CAS may also
be influenced by the imprecision of measurement of
the triglycerides. Conflicting results are reported con-
cerning the role of serum lipids as cardiovascular risk
factors [39]. The negative association between BMI
and any severe CAS is also reported for peripheral ar-
terial disease [20, 41, 42]. One explanation might be
the selective mortality of obese persons with CAS, re-
sulting in a disappearance, or, even a reversal of the
association between BMI and CAS. Another expla-
nation might be the unfavourable risk profile of el-
derly subjects losing weight. The small number of
KDM subjects (n = 66) did not allow an extensive
analysis of determinants of CAS in this sub-group.
No significant association between smoking behav-
iour and CAS could be shown. Remarkably, a nega-
tive association between diastolic blood pressure and
CAS was found. A J-shaped association between di-
astolic blood pressure and the intimal media thick-
ness has recently been reported in elderly Caucasian
subjects [43]. In subjects with a diastolic blood pres-
sure less than 60 mmHg an increased thickness was
found. This finding may be explained by stiffening of
the carotid artery wall due to generalised atheroscle-
rosis. Furthermore, medial arterial calcification may
be involved in diabetic subjects.
Serum insulin is reported to be an independent
risk factor for the development of coronary heart dis-
ease [44–46]. Population-based studies evaluating the
role of specific insulin as a risk factor for non-inva-
sively diagnosed CAS are rare. Various studies using
intima media thickness as parameters of carotid ath-
erosclerosis reported conflicting results regarding
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the associations with insulin levels [34, 36, 47]. In the
present study, neither fasting nor 2-h post-load spe-
cific insulin levels were associated with any severe
CAS in univariate and multivariate analyses. Exclu-
sion of the diabetic subjects treated with oral hypo-
glycaemic agents or insulin did not alter the relation-
ship (data not shown). The same association has pre-
viously been reported for insulin and peripheral arte-
rial disease [20, 48]. One reason may be the large in-
ter-individual variability of insulin levels, which may
be explained by two concurrent phenomena, affect-
ing the insulin levels in opposite directions in diabetic
subjects: peripheral insulin resistance and deficient
insulin production in the pancreas. Another explana-
tion may be that the deleterious effects of insulin re-
sistance and/or deficiency are mediated by resulting
metabolic disturbances, such as hyperglycaemia or
dyslipidaemia, and are not caused by the direct ef-
fects of (pro)insulin [22, 49].
The final conclusion is that, after correction for
cardiovascular risk factors, glycated haemoglobin,
2-h post-load plasma glucose and serum fructosamine
(borderline) are independent determinants of any se-
vere CAS, whereas specific insulin is not. As these
data result from a cross-sectional survey, longitudinal
studies are needed to further explore these associa-
tions, their underlying mechanisms and their clinical
consequences.
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